LINDSTROM RICHARD L MD
SEC insider (Form 3/4/5 filer). CIK 0001242177. Director at OCULAR THERAPEUTIX, INC (OCUL) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in ORLANDO, FL.
Companies LINDSTROM RICHARD L MD has filed insider reports for
- OCULAR THERAPEUTIX, INC (OCUL): Director
- LENSAR, Inc. (LNSR): Director
LINDSTROM RICHARD L MD
CIK: 0001242177
Transaction Breakdown
Open Market Buys (P)2 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2026OCUL
OCULAR THERAPEUTIX, INC
AwardDirect14K shares- - Jun 3, 2026LNSR
LENSAR, Inc.
AwardDirect17.4K shares- - Feb 20, 2026OCUL
OCULAR THERAPEUTIX, INC
PurchaseDirect60.2K shares at avg. $7.66$461K - Jun 11, 2025OCUL
OCULAR THERAPEUTIX, INC
AwardDirect14K shares- - May 23, 2025LNSR
LENSAR, Inc.
AwardDirect7.4K shares- - May 8, 2025OCUL
OCULAR THERAPEUTIX, INC
PurchaseDirect10K shares at avg. $6.96$70K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  OCUL OCULAR THERAPEUTIX, INC | Award | 14,000 | - | $0 | Direct |
| Jun 3, 2026 |  LNSR LENSAR, Inc. | Award | 17,421 | - | $0 | Direct |
| Feb 20, 2026 | OCUL OCULAR THERAPEUTIX, INC | Purchase | 60,229 | $7.66 | $461,354 | Direct |
| Jun 11, 2025 | OCUL OCULAR THERAPEUTIX, INC | Award | 14,000 | - | - | Direct |
| May 23, 2025 | LNSR LENSAR, Inc. | Award | 7,374 | - | - | Direct |
| May 8, 2025 | OCUL OCULAR THERAPEUTIX, INC | Purchase | 10,000 | $6.96 | $69,600 | Direct |
1-6 of 6 transactions